Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

sheeba farhat

Sheeba Farhat Joined Medical Dialogues in 2018 to report on the latest Education news. A Graduate of the University of Delhi, she specializes in covering stories related to Medical Education updates. For inquiries or further information, you can reach her at editorial@medicaldialogues.in.

Home

sheeba farhat

Articles By : sheeba farhat

UK MHRA to Allow Drug Reviews Without Animal Testing by 2026, Issues Draft Framework

sheeba farhat26 March 2026 11:19 PM IST

Bengaluru: Britain's medicines regulator said on Wednesday it will introduce a framework by the end of 2026, which would allow drugmakers to ask a...

Merck Nears USD 6 Billion Terns Pharma Deal Amid Keytruda Patent Expiry Push

sheeba farhat25 March 2026 11:18 PM IST

Mexico City: Pharmaceutical company Merck is nearing a roughly USD 6 billion all-cash deal to acquire biotech firm Terns Pharma, ‌the ⁠Financial...

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Pfizer, Valneva Lyme Disease Vaccine Shows Over 70% Efficacy in Late-Stage Trial

sheeba farhat25 March 2026 11:08 PM IST

Bengaluru: The U.S. drugmaker Pfizer and France's Valneva said on Monday their experimental Lyme disease vaccine showed more than 70% efficacy in a...

Gilead to Acquire Ouro Medicines in USD 2 Billion Deal to Boost Immunology Pipeline

sheeba farhat24 March 2026 10:15 AM IST

Bengaluru: Gilead Sciences said on Monday it would buy privately held biotech firm Ouro Medicines in a deal worth more than USD 2 billion to expand...

USFDA Flags Seizure Risk in Parkinson's Drugs, Orders Label Updates

sheeba farhat23 March 2026 11:45 AM IST

Bengaluru: The U.S. Food and Drug Administration said on Friday it has notified manufacturers of certain Parkinson's disease treatments to update...

Roche Drops Muscle Disease Drug After Trial Failure

sheeba farhat23 March 2026 11:30 AM IST

Bengaluru: Roche has stopped developing its experimental drug for two rare muscle diseases after it failed to show meaningful benefits, the Swiss...

Bristol Myers Squibb Wins USFDA Approval for Opdivo Combo in Hodgkin Lymphoma

sheeba farhat23 March 2026 11:15 AM IST

Bengaluru: The U.S. Food and Drug Administration said on Friday it approved Bristol Myers Squibb's combination treatment for adults and adolescents...

AstraZeneca to Set Up Cell Therapy Hub in Shanghai, Expands CAR-T Capabilities in China

sheeba farhat22 March 2026 1:18 PM IST

Shanghai: AstraZeneca said on Thursday it will build a cell therapy manufacturing and supply base and an innovation centre in Shanghai, aiming to...

Novo Nordisk cuts Wegovy price in South Africa for a second time

USFDA Approves Higher-Dose Wegovy to Boost Weight Loss Outcomes

sheeba farhat21 March 2026 11:00 AM IST

Washington: Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more...

Lilly's Retatrutide Shows Strong Sugar, Weight Loss Gains in Late-Stage Trial

sheeba farhat21 March 2026 10:30 AM IST

Bengaluru: Eli Lilly's next-generation obesity drug showed a reduction in blood sugar levels during a late-stage trial, the drugmaker said on...

GSK Gets USFDA Nod for Liver Disease-Related Itching Drug Lynavoy

sheeba farhat20 March 2026 11:26 PM IST

London: The U.S. Food and Drug Administration approved GSK's drug for severe relentless itching caused by ‌a type ⁠of ⁠liver disease, the company said...

DCGI Orders Audits, Steps Up Action on GLP-1 Weight Loss Drugs Misuse and Marketing

Semaglutide Patent Expiry Sparks Generic Rush in India, Prices Set to Drop Sharply

sheeba farhat20 March 2026 11:13 PM IST

Hyderabad: India's market for diabetes and weight-loss drugs is set for a shake-up as Danish drugmaker Novo Nordisk's patent on semaglutide expires...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok